Action Halo Collective - HALO

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

0,02

Prix Achat

0,02

Prix Vente

0,02

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

0,02

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Halozyme to Report Fourth Quarter and Full Year 2024 Financial and Operating Results

Halozyme to Report Fourth Quarter and Full Year 2024 Financial and Operating Results PR Newswire SAN DIEGO...

Form 144 - Report of proposed sale of securities

CHMP Issues Positive Opinion for Subcutaneous RYBREVANT®(amivantamab) Co-Formulated with ENHANZE® for the Treatment of Patients with Advanced EGFR-Mutated Non-Small Cell Lung Cancer

CHMP Issues Positive Opinion for Subcutaneous RYBREVANT®(amivantamab) Co-Formulated with ENHANZE® for the...

Form 8-K - Current report

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	-5.13	-99.6116504854	5.15	5.75	0.015	1328200	0.43355476	CS
260	-0.405	-95.2941176471	0.425	35	0.015	2666733	0.36991871	CS

HALO - Frequently Asked Questions (FAQ)

What is the current Halo Collective share price?

The current share price of Halo Collective is $ 0,02

What is the 1 year trading range for Halo Collective share price?

Halo Collective has traded in the range of $ 0,00 to $ 0,00 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
CDMNCanadian Manganese Company Inc	$ 0,03 (50,00%)	406,99k
FHFilament Health Corp	$ 0,03 (50,00%)	18k
VERSVerses AI Inc	$ 1,37 (9,60%)	397,1k
GRAMGold Flora Corporation	$ 0,065 (8,33%)	75k
ALGOLight AI Inc	1,01 (5,21%)	402,14k
INXDINX Digital Company Inc	$ 0,06 (-14,29%)	41,5k
JPEGPioneer Media Holdings Inc	$ 0,12 (-14,29%)	37,34k
MAXQMaritime Launch Services Inc	$ 0,035 (-12,50%)	928,07k
VRNOVerano Holdings Corp	$ 1,49 (-9,70%)	145,15k
BTQBTQ Technologies Corp	$ 3,15 (-7,89%)	191,48k
MLMMcfarlane Lake Mining Limited	$ 0,065 (-7,14%)	1,84M
MAXQMaritime Launch Services Inc	$ 0,035 (-12,50%)	928,07k
DEFIValour Inc	$ 4,75 (-2,46%)	681,03k
CBSTCannabist Company Holdings Inc	$ 0,085 (0,00%)	444,87k
CDMNCanadian Manganese Company Inc	$ 0,03 (50,00%)	406,99k

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Halo Collective Inc (HALO)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

HALO Dernières nouvelles

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Halozyme to Report Fourth Quarter and Full Year 2024 Financial and Operating Results

Form 144 - Report of proposed sale of securities

CHMP Issues Positive Opinion for Subcutaneous RYBREVANT®(amivantamab) Co-Formulated with ENHANZE® for the Treatment of Patients with Advanced EGFR-Mutated Non-Small Cell Lung Cancer

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Halozyme to Report Fourth Quarter and Full Year 2024 Financial and Operating Results

Form 144 - Report of proposed sale of securities

HALO - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Halo Collective Inc (HALO) Cours

Halo Collective Inc (HALO)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

HALO Dernières nouvelles

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Halozyme to Report Fourth Quarter and Full Year 2024 Financial and Operating Results

Form 144 - Report of proposed sale of securities

CHMP Issues Positive Opinion for Subcutaneous RYBREVANT®(amivantamab) Co-Formulated with ENHANZE® for the Treatment of Patients with Advanced EGFR-Mutated Non-Small Cell Lung Cancer

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Halozyme to Report Fourth Quarter and Full Year 2024 Financial and Operating Results

Form 144 - Report of proposed sale of securities

HALO - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités